ALPS
Price
$0.40
Change
+$0.01 (+2.56%)
Updated
Oct 2 closing price
Capitalization
66.56M
Intraday BUY SELL Signals
SLDB
Price
$6.85
Change
-$0.13 (-1.86%)
Updated
Oct 2 closing price
Capitalization
780.6M
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALPS vs SLDB

ALPS vs SLDB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALPS vs. SLDB commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPS is a StrongBuy and SLDB is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
SLDB: Fundamental Ratings
SLDB
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALPSSLDB
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
22%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
26%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
31%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 15 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 4 days ago
66%
Bullish Trend 2 days ago
73%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (ALPS: $0.39 vs. SLDB: $6.98)
Brand notoriety: ALPS and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALPS: 12% vs. SLDB: 143%
Market capitalization -- ALPS: $66.56M vs. SLDB: $780.6M
ALPS [@Biotechnology] is valued at $66.56M. SLDB’s [@Biotechnology] market capitalization is $780.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPS’s FA Score shows that 1 FA rating(s) are green while SLDB’s FA Score has 2 green FA rating(s).

  • ALPS’s FA Score: 1 green, 4 red.
  • SLDB’s FA Score: 2 green, 3 red.
According to our system of comparison, SLDB is a better buy in the long-term than ALPS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPS’s TA Score shows that 3 TA indicator(s) are bullish while SLDB’s TA Score has 5 bullish TA indicator(s).

  • ALPS’s TA Score: 3 bullish, 4 bearish.
  • SLDB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SLDB is a better buy in the short-term than ALPS.

Price Growth

ALPS (@Biotechnology) experienced а -2.50% price change this week, while SLDB (@Biotechnology) price change was -6.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

SLDB is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ALPS
Daily Signal:
Gain/Loss:
SLDB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BKMI24.930.09
+0.38%
BNY Mellon Municipal Intermediate ETF (BKMI)
OND32.78N/A
N/A
ProShares On-Demand ETF (OND)
ITDI42.37-0.07
-0.16%
iShares LifePath Target Date 2065 ETF (ITDI)
HAWX45.32-0.08
-0.18%
iShares Currency Hedged MSCI ACWI ex U.S. ETF (HAWX)
HYSD19.50-0.07
-0.36%
Columbia Short Duration High Yield ETF (HYSD)